For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Naltrexone HCL is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence.
Scope of the Report:
This report focuses on the Naltrexone HCL in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Naltrexone HCL is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. As a restricted drug, Naltrexone HCL manufacturers are limited. They mainly concentrated in Europe, India, USA and China.
Global naltrexone HCL consumption areas concentrate in Europe, India and USA. Europe is the largest naltrexone HCL consumption area, which took 38.30% in 2015. India also took 21.44% and USA naltrexone HCL consumption took 18.80% of globe.
The worldwide market for Naltrexone HCL is expected to grow at a CAGR of roughly 0.9% over the next five years, will reach 21 million US$ in 2023, from 20 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- - Taj Pharmaceuticals
- - Freedom Pharmaceuticals
- - Rusan
- - Sanofi
- - IVAX
- - Faran Shimi
- - Sun Pharma
- - Noramco
- - Haida Taicheng
Market Segment by Regions, regional analysis covers
- - North America (United States, Canada and Mexico)
- - Europe (Germany, France, UK, Russia and Italy)
- - Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- - South America (Brazil, Argentina, Colombia etc.)
- - Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- - Naltrexone HCL
- - Type II
Market Segment by Applications, can be divided into
- - Opioid Independence
- - Alcohol Independence
- - Other
There are 15 Chapters to deeply display the global Naltrexone HCL market.
Chapter 1, to describe Naltrexone HCL Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Naltrexone HCL, with sales, revenue, and price of Naltrexone HCL, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Naltrexone HCL, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Naltrexone HCL market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Naltrexone HCL sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source